Prognosis of the intrahepatic cholangiocarcinoma after resection: Hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Liu, Rui qing ^a,b   Shen, Shu jing ^a   Hu, Xiu feng ^b   Liu, Jie ^b   Chen, Li juan ^b   Li, Xing ya ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Hepatitis B virus; Intrahepatic cholangiocarcinoma; Prognosis; Survival

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BILIRUBIN; CA 19-9 ANTIGEN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; GEMCITABINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; OXALIPLATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DIABETES MELLITUS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; RADICAL RESECTION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; VACCINATION;

EID: 84885513572     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-99     Document Type: Article

References (25)

1. Ikai I, Itai Y, Okita K, et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 2004, 28(1):21-29. 10.1016/j.hepres.2003.08.002, 14734147.
2. Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet 2005, 366(9493):1303-1310. 10.1016/S0140-6736(05)67530-7, 16214602.
3. Wang W-L, Guang-yu G, Min H. Expressionandsignificance of hepatitis Bvirus genes inhumanprimaryintrahepatic cholangiocar-cinomaanditssurroundingtissue. Chin J Oncol 1996, 18(2):127-129.
4. Qu ZL, Zou SQ, Cui NQ, et al. Upregulation of human telomerase reverse transcriptase mRNA expression by in vitrotransfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells. World J Gastroenterol 2005, 11(36):5627-5632.
5. Zhang L, Cai JQ, Zhao JJ, et al. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2010, 101(3):233-238. 10.1002/jso.21488, 20169539.
6. Zhou HB, Wang H, Li YQ, et al. Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011, 17(10):1292-1303. 10.3748/wjg.v17.i10.1292, 3068264, 21455328.
7. Vitale F, Tramuto F, Orlando A, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection. J Med Virol 2008, 80(4):577-582. 10.1002/jmv.21121, 18297707.
8. Arase Y, Suzuki F, Suzuki Y, et al. Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance. Intervirology 2007, 50(3):161-165. 10.1159/000098958, 17259734.
9. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 2005, 16(2):ii93-ii96.
10. Yue M, Ying-Chun X, Lei T, et al. Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety. Exp Hematol & Oncol 2012, 1:11. 10.1186/2162-3619-1-11, 3514101, 23210562.
11. Chen LP, Li C, Wang C, et al. Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology 2012, 59(118):1765-1768.
12. Nanashima A, Sumida Y, Abo T, et al. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 2008, 98(7):535-539. 10.1002/jso.21142, 18814285.
13. Haruna Y, Saito K, Spaulding S, et al. Identification of bipotential progenitor cells in human liver development. Hepatology 1996, 23(3):476-481. 10.1002/hep.510230312, 8617427.
14. Ding F-X, Wang F, Yi-ming L, et al. Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma. Hepatology 2009, 49(5):1492-1502. 10.1002/hep.22816, 19206147.
15. Morise Z, Sugioka A, Tokoro T, et al. Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2010, 2(2):58-64. 2998957, 21160974.
16. Li F-H, Chen X-Q, Luo Y-H, et al. Prognosis of 84 intrahepatic cholangiocarcinoam patients. Chin J Cancer 2009, 28(5):528-532.
17. Jan YY, Yeh CN, Yeh TS, et al. Prognostic analysis of surgical treatment of periheral cholangiocarcinoma: two decades of experience at chang gung memorial hospital. World J Gas-troenterol 2005, 11(12):1779-1784.
18. Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000, 95(1):204-207. 10.1111/j.1572-0241.2000.01685.x, 10638584.
19. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002, 89(12):1525-1531. 10.1046/j.1365-2168.2002.02268.x, 12445060.
20. Cho SY, Park SJ, Kim SH, et al. Survival analysis of intrahepatic cholangiocarcinoam after resection. Ann Surg Oncol 2010, 17(7):1823-1830. 10.1245/s10434-010-0938-y, 20165987.
21. Nathan H, Aloia TA, Vauthey J-N, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009, 16(1):14-22. 10.1245/s10434-008-0180-z, 18987916.
22. Uenishi T, Yamazaki O, Yamamoto T, et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Surg 2005, 12(6):479-483.
23. Li HY, Zhou SJ, Li M, et al. Diagnosis and cure experience of hepatolithiasis- associated intrahepatic cholangiocarcinoma in 66 patients. Asian Pac J Cancer Prev 2012, 13(2):725-729. 10.7314/APJCP.2012.13.2.725, 22524851.
24. Zhao S-B, Cai-de L. Dignosis and treatment hepatolithias associated with cholangiocarcinoma:a report of 28 cases. Int J Surg 2010, 7(37):445-447.
25. Chun-xing L, Zhou J. Association between diabetes mellitus and the risk of extrahepatic cholangiocarcinoma: a Meta-analysis. Actauniversitats Medicinalis Nedicinalis Nanjing (Natural Science) 2011, 6(31):834-837.